Nutex Health (NASDAQ:NUTX) Trading Down 5.9% – Here’s What Happened

Nutex Health Inc. (NASDAQ:NUTX) shares were down 5.9% during trading on Tuesday . The stock traded as low as $115.00 and last traded at $110.75. Approximately 53,381 shares changed hands during mid-day trading, a decline of 28% from the average daily volume of 74,106 shares. The stock had previously closed at $117.66.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. Benchmark upped their price target on shares of Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a report on Thursday, May 15th. Maxim Group increased their target price on Nutex Health from $100.00 to $225.00 and gave the company a “buy” rating in a research note on Tuesday, May 20th. Finally, Wall Street Zen downgraded Nutex Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, May 22nd.

Nutex Health Trading Down 2.9%

The company has a current ratio of 1.77, a quick ratio of 1.74 and a debt-to-equity ratio of 3.36. The stock has a market capitalization of $634.44 million, a P/E ratio of -12.20 and a beta of 0.04. The business’s fifty day simple moving average is $133.49 and its two-hundred day simple moving average is $75.79.

Nutex Health (NASDAQ:NUTX) last released its earnings results on Tuesday, May 13th. The company reported $2.56 earnings per share for the quarter, beating the consensus estimate of ($0.15) by $2.71. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The business had revenue of $211.79 million during the quarter, compared to analysts’ expectations of $81.09 million.

Insider Transactions at Nutex Health

In other Nutex Health news, CFO Jon Christian Bates bought 1,000 shares of the firm’s stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average cost of $81.81 per share, for a total transaction of $81,810.00. Following the transaction, the chief financial officer now owns 4,888 shares in the company, valued at approximately $399,887.28. The trade was a 25.72% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 38.52% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE boosted its holdings in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock worth $66,000 after buying an additional 2,043 shares during the last quarter. Northern Trust Corp bought a new stake in Nutex Health in the fourth quarter valued at approximately $200,000. Millennium Management LLC acquired a new stake in Nutex Health in the fourth quarter worth $213,000. World Investment Advisors acquired a new position in Nutex Health in the fourth quarter valued at about $217,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in shares of Nutex Health in the fourth quarter worth about $231,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.